Skip to main content Skip to section navigation Skip to footer
Home
866.776.5907
Glassdoor
Linkedin
Twitter
YouTube

Header Utility

  • Client Services
    • Specimen Kits
    • Online Orders
    • Requisition Forms
  • About
    • Events
      • Molecular Tumor Board
      • Trade Shows
      • Webinars
      • Diagnostic Symposiums
    • Newsroom
      • Blog
      • Press Releases
      • Literature
      • Podcast
      • Videos
    • Our Team
    • Employee Benefits
    • Investors
    • NeoUniversity
    • Corporate Stewardship
    • Regulatory
      • Good Faith Estimate
      • Privacy
      • Terms of Use
  • Billing
    • Patients
    • Third Party Billing
  • Careers
  • Contact
  • NeoLINK Login

Main navigation

  • Diagnostic Services
    • Methodologies
      • Anatomic Pathology
      • Cytogenetics
      • FISH
      • Flow Cytometry
      • NGS
    • Sponsored Testing Programs
      • FOLR1 Ovarian Cancer Testing Program
      • KRAS Single Gene Test Program
    • Tech-Only Program Services
    • Laboratory Collaboration
    • Specialty Testing
      • Neo Comprehensive - Heme Cancers
      • Neo Comprehensive - Solid Tumor
      • COMPASS®
      • CancerTYPE ID®
      • Hereditary Cancer
      • InVisionFirst®-Lung Liquid Biopsy
      • Liquid Biopsy
      • NeoTYPE®
      • Early-Stage NSCLC Panel
  • Pharma Services
    • Why Choose NEO
      • Expertise
    • CDx Services
    • Project Requirements and Compliance
    • Lab Services
      • Anatomic Pathology
      • Molecular
      • Multiplexed Immunofluorescence
      • Flow Cytometry
      • FISH & Cytogenetics
      • CAR-T Services
  • Informatics & Data Solutions
  • Patients
    • Billing
    • In-home Blood Draws
    • Testing Terminology
    • Testing Methods and Tumor Profiling
    • Sponsored Testing Programs for Patients
    • Frequently Asked Questions
    • InVisionFirst®-Lung (Liquid Biopsy)
  • Test Menu
  • Search
Mobile Nav

IR Calendar

Investor Relations News & Events IR Calendar
Investor Relations
Investor Relations
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • Tear Sheet
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • ESG Report

  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Literature
  • Email Alerts

Third Quarter 2023 Financial Results Conference Call

Nov 6, 2023 4:30 pm EST
Earnings Release HTML PDF
Earnings Webcast Audio
Presentation PDF
10-Q HTML PDF
  • Accessibility statement
  • Email alerts
  • Company profile
  • RSS news feed
Home

Footer navigation

  • Diagnostic Services
  • Pharma Services
  • Informatics & Data Solutions
  • Patients
  • Test Menu
  • Search

Contact Us

  • 9490 NeoGenomics Way
  • Fort Myers, FL 33912
  • T: 239.768.0600
  • F: 239.690.4237
Glassdoor
Linkedin
Twitter
YouTube

More From Neo

  • FOLR1 Ovarian Cancer Testing Program
  • Lung Cancer Testing
  • Biomarker Assist™ KRAS SGT
  • Investigator-Initiated Trials (IIT) Request

NeoNEWS Sign Up

Receive weekly updates on NeoGenomics tests, research, events, and publications.

One Lab.
Vital Answers.
Transforming Care for Cancer Patients.

Footer Utility

  • Client Services
  • About
  • Billing
  • Contact
  • Careers
  • NeoLink Login

Copyright © 2024 NeoGenomics Laboratories. All rights Reserved. Privacy. Privacy Settings. Terms. Licensing. Do not sell or share my personal information.

Main navigation

  • Diagnostic Services
    • Methodologies
      • Anatomic Pathology
      • Cytogenetics
      • FISH
      • Flow Cytometry
      • NGS
    • Sponsored Testing Programs
      • FOLR1 Ovarian Cancer Testing Program
      • KRAS Single Gene Test Program
    • Tech-Only Program Services
    • Laboratory Collaboration
    • Specialty Testing
      • Neo Comprehensive - Heme Cancers
      • Neo Comprehensive - Solid Tumor
      • COMPASS®
      • CancerTYPE ID®
      • Hereditary Cancer
      • InVisionFirst®-Lung Liquid Biopsy
      • Liquid Biopsy
      • NeoTYPE®
      • Early-Stage NSCLC Panel
  • Pharma Services
    • Why Choose NEO
      • Expertise
    • CDx Services
    • Project Requirements and Compliance
    • Lab Services
      • Anatomic Pathology
      • Molecular
      • Multiplexed Immunofluorescence
      • Flow Cytometry
      • FISH & Cytogenetics
      • CAR-T Services
  • Informatics & Data Solutions
  • Patients
    • Billing
    • In-home Blood Draws
    • Testing Terminology
    • Testing Methods and Tumor Profiling
    • Sponsored Testing Programs for Patients
    • Frequently Asked Questions
    • InVisionFirst®-Lung (Liquid Biopsy)
  • Test Menu
  • Search

Header Utility

  • Client Services
    • Specimen Kits
    • Online Orders
    • Requisition Forms
  • About
    • Events
      • Molecular Tumor Board
      • Trade Shows
      • Webinars
      • Diagnostic Symposiums
    • Newsroom
      • Blog
      • Press Releases
      • Literature
      • Podcast
      • Videos
    • Our Team
    • Employee Benefits
    • Investors
    • NeoUniversity
    • Corporate Stewardship
    • Regulatory
      • Good Faith Estimate
      • Privacy
      • Terms of Use
  • Billing
    • Patients
    • Third Party Billing
  • Careers
  • Contact
  • NeoLINK Login
Phone number
Glassdoor Icon
Linkedin Icon
Twitter Icon
YouTube Icon